-
Most Popular
Search Results
240 results for fsa
Ground Cinnamon Recalls: What to Know as FDA Issues Alert Over Lead Levels
New ground cinnamon recalls are in effect as the FDA warns consumers about increased lead levels in some of these products.
Get Your Money Out of These 3 Healthcare Stocks ASAP
Many companies in the healthcare sector have great outlooks but these healthcare stocks to sell are facing very tough challenges
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?
Kazia Therapeutics stock soared after positive clinical trials, which raises its profile amongst pharmas looking to buy promising candidates.
FSP Stock Earnings: Franklin Street Props Meets EPS, Beats Revenue for Q2 2024
FSP stock results show that Franklin Street Props met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Why Is vTv Therapeutics (VTVT) Stock Down 46% Today?
VTv Therapeutics stock is falling on Monday as VTVT investors react to the company’s cadisegliatin clinical program being put on hold.
PSA Stock Earnings: Public Storage Beats EPS, Misses Revenue for Q2 2024
PSA stock results show that Public Storage beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
3 Contrarian Stock Picks to Buy Against the Market Consensus
Discover three contrarian stock picks with strong fundamentals that defy current market trends and offer significant rebound potential.
HTLF Stock Earnings: Heartland Financial USA Beats EPS, Misses Revenue for Q2 2024
HTLF stock results show that Heartland Financial USA beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Why Is Processa Pharmaceuticals (PCSA) Stock Up 29% Today?
Processa Pharmaceuticals stock is up on Tuesday as PCSA investors react to approval for a Phase 2 clinical trial of NGC-Cap.
The Top 3 Biotech Stocks to Buy Now Summer 2024
These biotech stocks are well-positioned to generate high returns for investors due to their significant growth prospects.
Longeveron (LGVN) Stock Pops on Phase 2 Trial Updates
The good news on Lomecel-B comes at an opportune time for Longeveron and LGVN stock — it could attract a buyer.
Student Loan Forgiveness Updates: Check Your Email as Biden Doubles Down
President Joe Biden’s Administration continues to push forward with student loan forgiveness as it starts sending emails to borrowers.
7 Undervalued Stocks With 500% Upside Potential After Coming Rate Cuts
These seven undervalued stocks have the potential to deliver up to 500% returns as interest rates are expected to be cut in the coming months.
Spirit Airlines Changes: Get Ready for Higher Fares, More In-Flight Perks
Spirit Airlines is changing up its pricing options to offer more perks to customers who choose to pay more for their seats.
3 AI-Powered Healthcare Stocks Transforming Medicine
Invest in AI healthcare stocks to benefit significantly from tech that could propel the healthcare market to $148.4 billion by 2029.
MSA Stock Earnings: MSA Safety Beats EPS, Beats Revenue for Q2 2024
MSA stock results show that MSA Safety beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Trade of the Day: Seabridge Gold (SA) Stock Is Lighting Up the Options Market
With options traders putting the spotlight on Seabridge Gold, it’s time to have a look at SA stock and its strong fundamentals.
Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth
Healthcare stocks offer wealth to investors through a mix of steady performance, growth and income not to be overlooked.
JPMorgan Just Cut Its Price Target on These 3 Stocks: July 31, 2024
Analysts from JPMorgan Chase have expressed their concern about the outlook for these stocks with lowered price targets.
Why Is Lipella Pharmaceuticals (LIPO) Stock Up 149% Today?
Lipella Pharmaceuticals stock is up on Monday after the company notified LIPO investors of a Phase 2a clinical trial of LP-310 starting.
3 – 10 of 240 results
